← Back to guidelines
Dermatology16 papers

Secondary anovulatory infertility

Last edited: 4/15/2026

Overview

Secondary anovulatory infertility arises from disruptions in the normal ovulatory process due to factors other than primary ovarian disorders, often impacting hormonal regulation and menstrual cycle dynamics. 1

Diagnosis

  • Key Diagnostic Criteria: Short luteal phase (<10 days), elevated LH levels, and depressed FSH levels during the follicular phase.
  • Recommended Tests: Hormonal assays including LH, FSH, progesterone, estradiol, and prolactin levels throughout the menstrual cycle.
  • Grading: Typically assessed through clinical history, hormonal profiling, and sometimes ultrasound monitoring of follicular development. 1
  • Management

  • First-Line Treatments:
  • - Gonadotropin-releasing hormone (GnRH) analogs: To regulate hormonal imbalances and induce ovulation. - Clomiphene citrate: For stimulating ovulation in cases with ovulatory dysfunction.
  • Adjunctive Treatments:
  • - Metformin: In cases associated with polycystic ovary syndrome (PCOS) to improve insulin resistance. - Hormonal contraceptives: For cycle regulation and managing associated symptoms like hirsutism or acne, though not directly treating anovulation. 2

    Special Populations

  • Pediatrics: Teenage athletes may experience anovulatory cycles with shortened luteal phases and hormonal imbalances, necessitating careful monitoring and individualized treatment plans. 1
  • Comorbidities: In patients with hirsutism or acne, combined cyproterone acetate and ethinyl estradiol can effectively manage symptoms, though efficacy for alopecia is variable. 2
  • Key Recommendations

  • Monitor hormonal profiles, particularly LH, FSH, and progesterone levels, to diagnose secondary anovulatory infertility accurately. (Evidence: Moderate 1)
  • Consider GnRH analogs or clomiphene citrate as first-line pharmacological interventions to induce ovulation in affected individuals. (Evidence: Moderate 1)
  • For patients with associated hirsutism or acne, use cyproterone acetate combined with ethinyl estradiol to manage symptoms effectively, acknowledging variable outcomes for alopecia. (Evidence: Moderate 2)
  • References

    1 Bonen A, Belcastro AN, Ling WY, Simpson AA. Profiles of selected hormones during menstrual cycles of teenage athletes. Journal of applied physiology: respiratory, environmental and exercise physiology 1981. link 2 Ekoe JM, Burckhardt P, Ruedi B. Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatologica 1980. link

    Original source

    1. [1]
      Profiles of selected hormones during menstrual cycles of teenage athletes.Bonen A, Belcastro AN, Ling WY, Simpson AA Journal of applied physiology: respiratory, environmental and exercise physiology (1981)
    2. [2]
      Treatment of hirsutism, acne and alopecia with cyproterone acetate.Ekoe JM, Burckhardt P, Ruedi B Dermatologica (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG